Tag: implantations
CARMAT achieves a structuring year in 2023 by reaching the milestone of 50 implantations of the Aeson® artificial heart and presents its development prospects – 01/15/2024 at 07:05
50 patients have benefited from CARMAT’s Aeson® artificial heart since the first implantation in 2013 Aeson® establishes itself as an essential breakthrough innovation in the treatment of advanced…
Carmat: The Stock Exchange welcomes the resumption of implantations by Carmat of its artificial heart in France
(BFM Bourse) – The French company announced on Wednesday that it had carried out the first implantation of its artificial hearts at the end of December as part of the…
Carmat announces the effective resumption of implantations of its Aeson artificial heart – 2022-11-21 at 18:25
(AOF) – A medtech company, Carmat announces the effective resumption of the implantations of its Aeson artificial heart on a commercial basis. On October 25, Carmat announced that the notified…
CARMAT announces the effective resumption of implantations of its Aeson® artificial heart on a commercial basis – 2022-11-21 at 07:00
CARMAT (FR0010907956, ALCAR, PEA-PME eligible), designer and developer of Aeson®, the most advanced total artificial heart in the world, aimed at offering a therapeutic alternative to patients suffering from end-stage…
Carmat authorized to resume implantations of the Aeson artificial heart in the commercial context – 2022-10-25 at 09:30
(AOF) – The medtech Carmat has obtained the necessary regulatory authorizations to resume the implantations of the Aeson artificial heart in the commercial context. Notified Body Dekra approved all changes…
Pixium Vision announces that it has reached the recruitment targets for its European pivotal study PRIMAvera and the implantations should be completed by the end of 2022 – 09/19/2022 at 07:00
Pixium Vision announce what to have achieved I rec objectives r utely of its European pivotal study PRIMAvera and them settlements should be completed by the end of 2022 In…
Carmat is counting on “strong demand” for the resumption of the implantations of its artificial heart
Carmat is counting on strong demand for the resumption of implantations of its artificial heart | Photo credits: Carmat PARIS, September 15 (Reuters) – Carmat confirmed in a press release…
Carmat: Carmat artificial heart implantations will resume in October
(BFM Bourse) – On the occasion of the publication of its half-year results, the company reiterated that it expects a resumption next month of the implantations of its Aeson heart…
Carmat ready to resume the implantations of its artificial heart, the title jumps
Carmat ready to resume the implantations of its artificial heart, the title jumps | Photo credits: Carmat PARIS, Sept 15 (Reuters) – Carmat confirmed on Thursday that it is preparing…
Carmat: The Stock Exchange heavily sanctions Carmat, which plans to resume implantations in October
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…